Japan's Nikkei tracks Wall Street losses; BOJ coy on hike timing
Updates with closing prices
By Kevin Buckland
TOKYO, Nov 18 (Reuters) -Japan's Nikkei share average fell on Monday, taking cues from losses on Wall Street at the end of last week, after Bank of Japan chief Kazuo Ueda failed to offer strong hints on the timing of additional interest rate hikes.
Japanese technology stocks tracked losses among U.S peers, while shares of local drugmakers declined after a noted vaccine sceptic was appointed to head the U.S. health department.
Ueda reiterated that the central bank is prepared to raise borrowing costs if the economy aligns with its forecasts, while cautioning about external risks, including uncertainty over the U.S. economy and volatile financial markets.
The Nikkei .N225 ended the day down 1.09% at 38,220.85.
The broader Topix .TOPX lost 0.73%.
Japanese stocks got some respite after the yen retreated to the weaker side of 155 per dollar JPY=EBS from as strong as 153.84 during the session, but the currency was back at 154.32, as of 0633 GMT.
A strong yen reduces the value of overseas revenue for Japan's heavyweight exporters, and also makes Japanese stocks more expensive for foreign investors.
On Friday, all three of the main Wall Street indexes declined and the Philadelphia SE Semiconductor Index .SOX slumped 3.4%.
The initial euphoria over a Donald Trump election win ushering in easier regulation and bigger fiscal spending shifted last week to worries over the potential for higher inflation under his policies that could slow Federal Reserve rate cuts.
His cabinet picks have also caused some concerns, including the appointment of Robert Kennedy Jr, who has spread misinformation on vaccines, to head the Department of Health and Human Services.
Chugai Pharmaceutical 4519.T slid 10%, making drugmakers .IPHAM.T the worst performers among the Tokyo Stock Exchange's 33 industry groups by a wide margin.
"Whether the Trump trade is over or just on pause is not possible to discern at the moment," said Kazuo Kamitani, an equities strategist at Nomura Securities.
"My personal feeling is that the market will be turbulent all of this month."
Among tech names, Tokyo Electron 8035.T dropped 1.59% and startup investor SoftBank Group 9984.T fell 2.09%.
Nvidia supplier Advantest 6857.T was volatile, dropping as much as 3.58% before bouncing as much as 1.38% and eventually ending the day with a 0.39% loss.
Nvidia's earnings report on Wednesday will be one of the most closely watched market events of the week.
Reporting by Kevin Buckland; Editing by Janane Venkatraman and Sherry Jacob-Phillips
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
